Constructive Bio

Constructive Bio is a biotechnology startup based in the United Kingdom, founded in 2021. The company's slogan, "Realising the potential of genome rewriting to drive the next generation of bioprocesses and biopharmaceuticals," encapsulates its core mission. Leveraging its platform, which is a result of the work in Prof. Jason Chin's laboratory at the MRC Laboratory of Molecular Biology in Cambridge, Constructive Bio aims to fundamentally reprogram the genetic code and create novel molecules previously unattainable through natural processes. With a recent £43.00M Series A investment from investors including Paladin Capital Group, Ahren Innovation Capital, ND Capital, OMX Ventures, Fine Structure Venture, and Jonathan Milner, Constructive Bio is poised to advance its pioneering research and development in the field of biotechnology.